Pfizer(US:PFE) WSJ Newsยท2025-09-30 18:02Drug Pricing & Accessibility - Pfizer commits to offering all prescription medications to Medicaid at most favored nation prices, aiming to significantly reduce Medicaid costs [1] - Pfizer agrees to provide some popular medications to all consumers at heavily discounted prices, ranging from 50% to 100% off, available for direct purchase online via a federal government website [2] - All new medications introduced by Pfizer to the American market will be sold at reduced most favored nation costs, aligning with prices paid by other countries [3] - The agreement aims to bring down drug prices immediately for Americans [8] Manufacturing & Investment - Pfizer will invest $70 billion to reshore domestic manufacturing facilities, relocating production to the United States [3][4] - Pfizer commits to source the production of medicines consumed in the US from within the US, unleashing its investment portfolio in the country [5] - Pfizer is granted a three-year grace period from tariffs as long as they move production to the US [5] Negotiation & Tariffs - The administration is negotiating deals with other companies, with Pfizer being the first [6] - The administration is prepared to impose tariffs of an equivalent amount if companies refuse to make a deal, removing the advantage of non-compliance [7]